Clinical trial
EndoBarrier TM Gastrointestinal Liner Diabetes Trial
NCT02459561 · Imperial College London, Other · Unknown status
Key facts
| NCT number | NCT02459561 |
|---|---|
| Title | EndoBarrier TM Gastrointestinal Liner Diabetes Trial |
| Official title | A Randomised Controlled Trial of a Duodenal Sleeve Bypass Device (EndoBarrier)Compared With Standard Medical Therapy for the Management of Obese Subjects With Type 2 Diabetes |
| Acronym | EndoBarrier |
| Lead sponsor | Imperial College London, Other |
| Collaborators | National Institute for Health Research, United Kingdom University Hospital Southampton NHS Foundation Trust Brunel University University of Surrey |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Overweight and Obesity, Diabetes |
| Intervention type | Device, Other |
| Interventions | EndoBarrier TM Gastrointestinal Liner, Best Medical Care |
| Enrollment | 170 |
| Start date | Mar 1, 2015 |
| Primary completion | Oct 18, 2018 |
| Completion | May 15, 2019 |
| First posted | Jun 2, 2015 |
| Last update posted | Apr 16, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: